AccenGen Therapeutics, Inc. logo

AccenGen Therapeutics, Inc.

AccenGen Therapeutics, Inc. is an early-stage pharmaceutical company focused on developing products using soluble epoxide hydrolase (sEH) inhibitors (sEHI) and dual sEH/COX inhibitors for indications with fibrotic etiologies and highest unmet needs.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.accengen.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
333 First Street. Suite C., CA 94105
San Francisco
United States
Email
Contact Number
+1 310-903-9790

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/accengen-therapeutics” connections=”true” suffix=””]